Stay updated on Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial

Sign up to get notified when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record is displayed with its design, quizartinib and salvage-chemotherapy arms, outcomes, eligibility criteria, locations, and data-sharing information.
    Difference
    100%
    Check dated 2026-10-04T08:18:45.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the expected study record content with a standard error page. As a result, essential study information is not accessible on this page.
    Difference
    17%
    Check dated 2026-09-20T02:24:15.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, indicating a small release likely for UI or maintenance. It does not appear to modify the study details.
    Difference
    0.0%
    Check dated 2026-08-29T23:51:27.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The Revision: v3.6.5 label is now shown, replacing the previous Revision: v3.6.4. This indicates a new build deployment without altering the study information or page functionality.
    Difference
    0.0%
    Check dated 2026-08-08T23:27:20.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.6.4' appears, replacing 'Revision: v3.6.3', signaling a minor platform update without changes to content or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-25T17:14:32.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor platform update without changes to the study content or user-facing details.
    Difference
    0.0%
    Check dated 2026-07-04T04:17:42.000Z thumbnail image

Stay in the know with updates to Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Quizartinib vs. Salvage Chemo in FLT3-ITD+ AML Clinical Trial page.